Education
Academic Background-
Ph.D. Chungnam National University, South Korea Pharmacokinetics | Completed: 2008
Publications (12)
Selected Scholarly Contributions
Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays.
Hwi-Yeol Yun
2017
Population pharmacokinetics of moxifloxacin, cycloserine, p-aminosalicylic acid and kanamycin for the treatment of multi-drug-resistant tuberculosis.
Hwi-Yeol Yun
2017
Development of a LC-MS/MS method for the determination of CKD-712 in rat plasma: Application to a pharmacokinetic study in rats.
Hwi-Yeol Yun
2017
BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen.
Hwi-Yeol Yun
2016
Effects of type 2 diabetes mellitus on the population pharmacokinetics of rifampin in tuberculosis patients.
Hwi-Yeol Yun
2015
Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: Consideration of genetic polymorphisms.
Hwi-Yeol Yun
2015
A novel HPLC-MS/MS method for the simultaneous determination of astemizole and its major metabolite in dog or monkey plasma and application to pharmacokinetics.
Hwi-Yeol Yun
2015
Quantitative determination of amisulpride in rat plasma by HPLC-MS/MS.
Hwi-Yeol Yun
2015
Absolute bioavailability and metabolism of aceclofenac in rats.
Hwi-Yeol Yun
2015
Development of QTc prolongation model incorporating circadian rhythm using harmonic model.
Hwi-Yeol Yun
2015
Semi-Mechanistic modelling and simulation of inhibition of platelet aggregation by antiplatelet agents.
Hwi-Yeol Yun
2014
A simple pharmacokinetic model of alendronate developed using plasma concentration and urine excretion data from healthy men.
Hwi-Yeol Yun
2014